NICOTINAMIDE ADENINE DINUCLEOTIDE 1G & TIRZEPATIDE'S SUCCESSOR : A UK UPDATE

The emerging interest in NAD+ supplementation, particularly at a significant dosage of one gram, continues to gain momentum within the UK healthcare community. At the same time , attention is firmly fixed on Retatrutide, a innovative GLP-1 analogue being viewed by many as a potential replacement